Samiksha Jaiswal (Editor)

Instituto Bioclon

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Industry
  
Biomedicine

Parent
  
Silanes Laboratories

Founded
  
1990

Number of employees
  
not known

Headquarters
  
Mexico City

Type of business
  
Private


Services
  
Antivenom research and development

The Instituto Bioclon S.A. de C.V. (Bioclon Institute) was formed in 1990 to research and develop F(ab’)2 antivenoms.

Contents

Operations

The Instituto Bioclon is located in Mexico City, Mexico and has a Certificación Internacional de Buenas Prácticas de Manufactura (International Certificate for Good Manufacturing Practices) which was granted to Bioclon by the Instituto Nacional de Vigilancia de Medicamentos y Alimentos, (INVIMA) (National Food and Drug Monitoring Institute), of the Ministerio de la Protección Social (Secretary of Social Protection) of Colombia, as well as by COFEPRIS, in Mexico.

Products

  • Coralmyn® - coral snake antivenom
  • Antivipmyn® - pit viper antivenom
  • Antivipmyn® TRI – Central and South American snakes
  • Antivipmyn® Africa – African snakes
  • Alacramyn® - scorpion antivenom
  • Reclusmyn® - brown recluse antivenom
  • Aracmyn® - black widow antivenom
  • The Bioclon Institute is the only Mexican company that has obtained an "orphan drug" status from the Food and Drug Administration (FDA) of the United States for three of its products.

    References

    Instituto Bioclon Wikipedia